Skip to main content area Skip to main content area Skip to institutional navigation Skip to search Skip to section navigation
Feedback

Leading healthcare regulatory society profiles Cary Coglianese for his leadership

July 17, 2018

In a two part profile, Penn Law’s Cary Coglianese was featured by The Regulatory Affairs Professionals Society (RAPS), as part of the Regulatory Focus series, ‘Focus on…,’ highlighting his leadership, views on regulatory excellence & future of healthcare regulation. 

In part one, Coglianese shares his thoughts on regulatory excellence, the respective roles of regulators and regulated industry, popular criticism of regulation as overly burdensome to business and more.

Following, in part two, he answers questions about regulatory harmonization, trends to watch and his own personal values, among other topics.

RAPS  is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS is headquartered in suburban Washington, DC, with chapters and affiliates worldwide.